UroLift

Highly Engaged Employees

UroLift, founded in 2004, is a prominent player in the medical devices and manufacturing sector. The company specializes in developing innovative solutions for urological conditions, specifically focusing on Benign Prostatic Hyperplasia (BPH). Their flagship product, the UroLift System, is an FDA-cleared medical technology designed to provide rapid relief for men suffering from enlarged prostate symptoms. By utilizing small, permanent implants to mechanically lift and hold the enlarged prostate tissue away from the urethra, the system effectively alleviates urinary blockage without the need for traditional, invasive surgery.

The UroLift System represents a significant advancement in medical technology, offering a minimally invasive outpatient procedure that avoids the long-term burdens associated with ongoing medication. This approach is specifically engineered to preserve sexual function and enhance the overall quality of life for patients. By providing a reliable alternative to major surgical interventions, UroLift addresses a critical need in the urology field. The procedure is performed in an outpatient setting, allowing for a faster recovery time compared to conventional surgical methods, which often require more extensive hospital stays and longer rehabilitation periods.

Operating with a workforce of 500-1,000 employees and generating $20.2M in annual revenue, UroLift maintains a strong market presence within the North American medical device landscape. The company continues to innovate within the BPH treatment space, competing with various urological specialty groups and medical centers. Meet UroLift's team to learn more about the leadership and operational expertise driving their mission to improve patient outcomes through advanced medical engineering. With a commitment to quality and clinicalView more...